Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative GOS for Stress, Anxiety and Cognition
NCT02953691Phase 2Withdrawn
- Start
- Jun 2017
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial. Primary endpoint: Change in Waking Salivary Cortisol. Planned start Jun 2017; status: withdrawn.
Beyond the preview
Go deeper on NCT02953691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02953691.